Skip to main content

Table 4 Listing of 62 Adverse events

From: The safety and efficacy of sequential intramuscular/oral ziprasidone treatment of acute episode in patients with schizophrenia: a multicenter, open-labeled study

 

Number of reports (n)

Percentage (%)

Extrapyramidal symptoms (Grade 1, Slightly without drug intervention)

10

12.0

Extrapyramidal symptoms (Grade 2–3, Serious need for drug intervention)

13

15.7

Prolonged QTc interval (≥ 450 ms)

7

8.4

Prolonged QTc interval (> 60 ms change from baseline)

6

7.2

Sinus tachycardia

2

2.4

Sinus bradycardia

1

1.2

Hypertension

6

7.2

Excessive sedation

10

12.0

Insomnia

6

7.2

Dizziness

1

1.2

  1. QTc the heart rate-corrected QT